The War between Bacteria and Bacteriophages by Orzechowska, Beata & Mohammed, Manal
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
The War between Bacteria and 
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Beata Orzechowska and Manal Mohammed
Abstract
The rapid emergence and dissemination of multidrug-resistant (MDR) bacteria 
represents a worldwide crisis concerning that humankind is re-entering the ‘pre-
antibiotics’ era. Before the discovery of antibiotics, bacteriophage therapy was 
widely enforced to combat bacterial infections. However, the discovery of penicillin 
in 1940 and other novel antibiotics replaced phage therapy, and they are being used 
as the first line of defence against pathogenic bacterial infections. Factors such as 
selective pressure resulted in bacteria becoming insensitive to one or multiple anti-
biotics, frequently leading to limited treatment options. This prompted a renewal 
of interest to the phage therapy that remains dubious due to its disadvantages such 
as host specificity and the development of bacterial resistance against phages. 
Evolution of bacterial genomes allowed bacteria to acquire vast mechanisms inter-
fering with phage infection such as inhibition of phage adsorption, prevention of 
phage entry, superinfection exclusion, restriction-modification and abortive infec-
tion. Interestingly, phages have developed diverse counterstrategies to circumvent 
bacterial anti-phage mechanisms including digging for receptors, adapting to new 
receptors and masking and modifying restriction sites. Understanding the complex 
dynamics of bacteria-phage interaction is a preliminary step towards designing 
synthetic phages that can overcome limitations of phage therapy and potentially 
lead to defeating MDR bacteria.
Keywords: bacteria-phage arms race, CRISPR system, anti-CRISPR system, 
superinfection exclusion (Sie), restriction-modification, abortive infection (Abi)
1. Introduction
Antimicrobial resistance is a global public health crisis. According to Public 
Health England [1], each year approximately 25,000 people die across Europe due 
to hospital-acquired infections caused by antibiotic-resistant and MDR bacteria 
such as Mycobacterium tuberculosis, Methicillin-resistant Staphylococcus aureus and 
multiresistant Gram-negative bacteria. Gram-negative infections include those 
caused by Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa [2]. 
Nevertheless, it is estimated that by 2050, the global yearly death toll will increase to 
10 million. Accelerating emerge of antimicrobial resistance seriously threatens the 
effectiveness of treatments for pneumonia, meningitis and tuberculosis, in addition 
to diminishing prevention of infections acquired during surgeries and chemothera-
pies. The crisis of the antibiotic resistance requires urgent, coordinated action. 
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Misuse and overuse of antibiotics must be controlled, implementation of new poli-
cies regarding prescriptions has to be internationally addressed; and development 
of new therapeutics is urgently required [1].
Félix d’Herelle, known as the father of bacteriophage (or phage) therapy [3], 
brought an evolutionary discovery of phages as therapeutics for various infections 
and conditions. Phage therapy was widely enforced in the 1920s and 1930s to com-
bat the bacterial infections. However, in the 1940s, the newly discovered antibiotics 
replaced the phage therapy (except Russia, Georgia and Poland) [4].
The emergence of MDR bacteria prompted a renewal of the interest to the phage 
therapy as an alternative treatment to overcome a broad spectrum of resistant 
bacterial infections. Phage therapy and phage cocktails that contain a mixture of 
different bacteria-specific phages, drawn interest within molecular biology and 
modern medical research as potential antimicrobials that could tackle the crisis of 
antimicrobial resistance. Nonetheless, the phage therapy remains controversial due 
to its disadvantages such as bacteriophage resistance: bacteria-phage evolutionary 
arms race that could put a burden on a long-time application of phage therapy as an 
anti-infectious agent [5].
Phage therapy has many advantages, primary because phages are very specific 
(generally limited to one species) and easy to obtain as they are widely distributed 
in locations populated by bacterial hosts including soil and seawater, and they do 
not have any known chemical side effects like antimicrobials [6].
Understanding host-phage interactions and ‘the war between bacteria and 
phages’ are steps towards designing engineering ‘broad-spectrum phage’ that can 
overcome the limitations of phage therapy and potentially overcome a wide range of 
resistant bacterial infections [6].
2. The evolutionary phage-host arms race
Phages are obligate intracellular parasites that distinctively infect bacterial cells. 
Although phages are very specific to their host, generally limited to one species, 
they pose an enormous threat to bacteria as in some habitats they outnumber their 
hosts by nearly 10-fold number [7]. Phages are the most abundant, ubiquitous 
and diversified organisms in the biosphere [8, 9]. Phage-host interaction and fight 
for the survival led to the evolution of bacterial and viral genomes and, therefore, 
to the evolution of resistance mechanisms. Bacteria, continuously, evolve many 
molecular mechanisms, driven by gene expression to prevent phage infection. These 
evolving phage-resistance mechanisms in bacteria induce the parallel co-evolution 
of phage diversity and adaptability [10, 11]. The co-evolving genetic variations and 
counteradaptations, in bacteria and phages, drive the evolutionary phage-host arm 
race [11, 12].
Leigh Van Valen, an evolutionary biologist, metaphorised the co-evolutionary 
arm race and proposed the Red Queen hypothesis [13].
‘It takes all the running you can do, to stay in the same place’ the Red Queen says 
to Alice in Through the Looking-Glass.
The Red Queen hypothesis proposes that to survive, microorganisms must 
constantly adapt, evolve and thrive against ever-evolving antagonistic microorgan-
isms within the same ecological niche [14].
Bacteria have developed various anti-phage mechanisms including non-adaptive 
defences (non-specific) and adaptive defences associated with Clustered Regularly 
Interspaced Short Palindromic Repeats (CRISPR) along with CRISPR-associated 
(Cas) proteins [7, 15–18].
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The non-specific adaptations (analogues to innate immunity in multicellular 
organisms) act as primary mechanisms to evade viral infection, and they include 
mechanisms that inhibit phage adsorption and prevent nucleic acid entry, superin-
fection exclusion systems, restriction-modification systems and abortive infection 
[7, 19].
On the other hand, the adaptive resistance (analogues to the acquired immunity 
in multicellular organisms) serves as a second line of defence, which is very effi-
cient and phage-specific.
Interestingly, it was observed that the bacterial anti-phage mechanisms are 
generally present in a genomic array, known as ‘defence islands’ [20]. The ‘defence 
islands’ are enriched in putative operons and contain numerous overrepresented 
genes encoding diverged variants of antiviral defence systems. Moreover, scientific 
evidence and characteristic operonic organisation of ‘defence islands’ show that 
many more anti-phage mechanisms are yet to be discovered [21–24].
Although bacteria have developed several resistance mechanisms against 
phages, phages can circumvent bacterial anti-phage mechanisms on the grounds 
of their genomic plasticity and rapid replication rates. These counterstrategies 
include point mutations in specific genes and genome rearrangements that allow 
phages to evade bacterial antiviral systems such as CRISPR/Cas arrays by using 
anti-CRISPR proteins and abortive infection by hijacking bacterial antitoxins, 
as well as escaping from adsorption inhibition and restriction-modification 
mechanisms [15–18].
This chapter will comment on the genetic basis of bacterial resistance to phages 
and different strategies used by phages to evade bacterial resistance mechanisms.
3. Preventing phage adsorption and phage’s counterstrategy
Phage adsorption to host-specific receptors on the cell surface is the initial step 
of the infection and host-phage interaction. Depending on the nature of bacteria, 
whether it is Gram-positive or Gram-negative proteins, lipopolysaccharides, tei-
choic acids and other cell surface structures can serve as irreversible phage-binding 
receptors [19]. These receptors might be present in the cell wall, bacterial capsules, 
slime layers, pili or flagella [25].
Bacteria have acquired various barriers to inhibit phage adsorption, such as 
blocking of phage receptors, production of extracellular matrix (e.g. capsule, 
slime layers) and production of competitive inhibitors [26–31]. The diversity of 
phage receptors in the host is influenced by co-evolutionary adaptations of phages 
to overcome these barriers [32]. This includes diversity-generating retroelements 
(DGRs) and phase variation mechanisms causing phenotypical differences within 
the bacterial colony [7, 33, 34].
Phase variation is a heritable, yet reversible process regulating gene expression 
in bacteria; genes can switch between a functional (expression) and a non-
functional state leading to phenotypical variations within the bacterial population 
even when strains have identical genotype. Sørensen et al. [35] investigated the 
underlying resistance mechanism of Campylobacter jejuni (NCTC11168) to phage 
F336. They have discovered that phage F336 relies on the hypervariable O-methyl 
phosphoramidate (MeOPN) modification of capsular polysaccharides (CPS) 
for successful adsorption to the bacterial surface. Nevertheless, loss of MeOPN 
receptor on the bacterial cell surface due to phase variation in the cj1421 gene 
encoding the MeOPN-GalfNAc transferase (MeOPN transferase attaches MeOPN 
to GalfNAc and Hep side chains of CPS) results in phage resistance [35, 36].
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DGRs are genetic elements diversifying DNA sequences and the proteins they 
encode ultimately mediating the evolution of ligand-receptor interactions. Error-
prone DGRs and random mutations in the bacterial genes encoding cell surface 
receptors lead to the alternation and change in the structural composition of the 
phage receptors, making them non-complementary to the phage’s anti-receptors, 
known as receptor-binding proteins (RBP) [34] (Figure 1(1)).
Yet, phage’s replication is exceedingly error-prone, therefore causing many ran-
dom mutations in the genes encoding the RBP or tail fibres. Phages also possess DGRs 
that mediate phage’s tropism by accelerating the variability in the receptor-coding 
genes through reverse transcription process [37]. The changes in the nucleotide 
sequence in the RBP-coding gene may ultimately lead to the adaptation to the modi-
fied receptor (Figure 1(2)), thus the ability to adsorb and infect the bacterial cell.
Unsurprisingly, bacteria also exhibit different strategies to block their receptors 
[28–31].
Figure 1(4) demonstrates the findings from studies conducted on Staphylococcus 
aureus by Nordstrom and Forsgren [38]. Mutants of Staphylococcus aureus produc-
ing higher anticomplementary protein A were found to adsorb fewer phages than 
Staphylococcus aureus mutants with scarce of protein A, which had an apparent increased 
ability to adsorb phages [38]. These findings indicate that some bacteria, including 
Staphylococcus aureus, are capable of production of surface proteins that mask the phage 
receptors making them inaccessible for phage recognition and attachment (Figure 1(3)).
Receptors located on bacterial cell surface serve a vital role in bacterial metabo-
lism; they may function as membrane porins, adhesions or chemical receptors [19]. 
Therefore, mutation or complete loss of the receptor might be lethal for bacteria. 
To inhibit phage adsorption, bacteria can produce surface molecules, such as 
exopolysaccharides.
Exopolysaccharides are extracellular polysaccharides acting as a physical barrier, 
composing slime or capsules surrounding bacterial cells that lead to inaccessible 
host receptors for efficient phage adsorption [39] (Figure 2). Studies conducted by 
Looijesteijn et al. [40] shown that exopolysaccharides produced by Lactococcus lactis 
function as external protection from phages and the cell wall destructing lysozyme, 
due to masked cell surface receptors [40].
Figure 1. 
Bacterial defence mechanisms preventing phage adsorption and phage’s counteradaptations. (1) Phage 
adsorption to a host-specific receptor site on a host cell surface. Bacterium evolves phage resistance by the 
modification of these cell surface receptors; phage is incapable of binding to the altered receptor. (2) Phage’s 
adaptation to these modifications through mutations in receptor-binding protein gene that leads to the 
co-evolution of bacterial genetic variation. Bacteria are also capable of producing proteins that mask the phage 
recognition site receptors (3 and 4), thus making the receptor inaccessible for phage adsorption [28–31]. Image 
courtesy of springer nature: https://www.ncbi.nlm.nih.gov/pubmed/20348932.
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Nevertheless, some phages evolved mechanisms allowing them to recognise 
these extracellular matrixes and degrade them by utilising hydrolases and lyases 
(Figure 2) [15–18]. The polysaccharide-degrading enzymes allow phages to gain 
access to the receptor that may lead to the viral propagation. They are commonly 
present bound to the RBPs or exist as free soluble enzymes from previously lysed 
bacterial cells [41].
4. Preventing phage DNA entry and phage’s counteradaptations
If phage bypasses primary antiviral strategies, it is now able to initiate 
infection by adsorption to a specific receptor site on a host cell surface through 
phage RBP [42, 43]. Upon interaction with the cell receptors, the phage injects 
its genetic material (single or double-stranded DNA or RNA) into the cyto-
plasm of the host. Depending on the nature of the phage and growth condi-
tions of the host cell, it follows one of the two life cycles: lytic or lysogenic 
(Figure 3).
In the lytic cycle, virulent phages degrade host’s genome leading to the bio-
synthesis of viral proteins and nucleic acids for the assembly of phage progeny. 
Eventually, the bacterial cell lysis, releasing a multitude of newly assembled phages, 
is ready to infect a new host cell [46].
In contrast, temperate phages might enter the lytic or lysogenic cycle, if the 
host cell exists in adverse environmental conditions that could potentially limit the 
number of produced progeny (Figure 3 demonstrates typical lifecycle of temperate 
phage using coliphage λ as an example) [44, 45]. In the lysogenic phase, repressed 
phage genome integrates into the bacterial chromosome as a prophage. This 
process causes the proliferation of prophage during replication and binary fission 
of bacterial DNA.
Figure 2. 
Bacterial strategies to inhibit phage adsorption and phage strategies to access host receptors. Some bacteria 
are capable of the production of exopolysaccharides, which act as an outer shield, protecting a cell from the 
phage infection [28–31]. If the phage does not possess any polysaccharide-degrading enzymes, it cannot access 
the host cell membrane receptor. However, some phages evolved mechanisms allowing them to recognise these 
extracellular matrixes and degrade them by the means of hydrolases and lyases [15–18]. Image courtesy of 
Springer Nature: https://www.ncbi.nlm.nih.gov/pubmed/20348932.
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Prophage only expresses a repressor protein-coding gene. The repressor protein 
binds to the operator sites of the other genes and ultimately inhibits synthesis of 
phage enzymes and proteins required for the lytic cycle.
When the synthesis of the repressor protein stops or if it becomes inactivated, a 
prophage may excise from the bacterial chromosome, initiating a lytic cycle (induc-
tion) which leads to the multiplication and release of virulent phages and lysis of a 
host cell [44, 45].
If the phage remains in the nearly dormant state (prophage), the lysogenic 
bacterium is immune to subsequent infection by other phages that are the same or 
closely analogous to the integrated prophage by means of Superinfection exclusion 
(Sie) systems [47].
Sie systems are membrane-associated proteins, generally, phage or prophage 
encoded, that prevent phage genome entry into a host cell [47]. Figure 4 shows 
the role of Sie system (proteins Imm and Sp) in blocking phage T4 DNA entry into 
Gram-negative Escherichia coli. Despite successful attachment to the phage-specific 
receptor, phage DNA is directly blocked by Imm protein from translocating into the 
cytoplasm of the cell. Sp system, on the other hand, prevents the degradation of the 
peptidoglycan layer by inhibiting the activity of T4 lysozyme [26–31, 48].
Figure 3. 
Lytic and lysogenic life cycles of a temperate coliphage λ that infects Escherichia coli [44, 45]. cos—cohesive 
sites: the joining ends that circularise the linear phage λ DNA. Image courtesy of Springer Nature: https://www.
nature.com/articles/nrg1089.
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5.  Host strategies to cleave invading genomes and evolutionary tactics 
employed by phages to bypass these antiviral mechanisms
The evolution of bacterial genomes allowed bacteria to acquire vast mechanisms 
interfering with every step of phage infection. In a case where a phage succeeded to 
inject its viral nucleic acid into a host cell, bacteria possess a variety of nucleic acid 
degrading systems such as restriction-modification (R-M) systems and CRISPR/Cas 
that protect bacteria from the phage invasion.
5.1 Restriction-modification systems
It has been reported that R-M systems can significantly contribute to bacterial 
resistance to phages [49].
R-M systems incorporate activities of methyltransferases (MTases) that catalyse 
the transfer of a methyl group to DNA to protect self-genome from a restriction 
endonuclease (REase) cleavage and REases, which recognise and cut foreign 
unmethylated double-stranded DNA at specific recognition sites, commonly 
palindromic. To protect self-DNA from the degradation, methylases tag sequences 
recognised by the endonucleases with the methyl groups, whereas unmethylated 
phage (nonself) DNA is cleaved and degraded (Figure 5) [26, 27, 50–52].
R-M systems are diverse and ubiquitous among bacteria. There are four known 
types of R-M within bacterial genomes (Figure 6). Their classification is mainly 
based on R-M system subunit composition, sequence recognition, cleavage posi-
tion, cofactor requirements and substrate specificity [26, 27, 50, 51].
Due to the diversity of R-M systems, phages acquired several active and passive 
strategies to bypass cleavage by REases. Passive mechanisms include reduction in 
restriction sites, modification and change of the orientation of restriction sites, 
whereas more specific, active mechanisms include masking of restriction sites, 
Figure 4. 
Superinfection exclusion systems preventing phage DNA entry in Gram-negative Escherichia coli. 
(a). Standard T4 phage: upon attachment to phage-receptor on the surface of the host cell, an inner-membrane 
protein aids the translocation of phage DNA into the cell’s cytoplasm. (b) Imm encoding phage T4: Imm 
protein directly blocks the translocation of the phage DNA into the cytoplasm of the cell. (c) Imm and Sp 
encoding phage T4: phage DNA is prevented from entering the cell’s cytoplasm by Imm; and Sp protein prevents 
degradation of the peptidoglycan layer by inhibiting the activity of T4 lysozyme [28–31]. Image courtesy of 
Springer Nature: https://www.ncbi.nlm.nih.gov/pubmed/20348932.
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stimulation of MTase activity on phage genome or degradation of an R-M system 
cofactor (Figure 7) [15–18].
Fewer restriction sites in the evading genome lead to the selective advantage of 
this phage as its DNA is less prone to cleavage and degradation by the host REase 
(Figure 7a). Also, some phages incorporate modified bases in their genomes 
that may lead to successful infection of the host cell as REase may not recognise 
the new sequences in the restriction sites. A decrease in the effective number of 
palindromic sites in DNA or change in the orientation of restriction-recognition 
sites can affect R-M targeting. Alternatively, the recognition sites within the viral 
genome can be too distant from each other to be recognised and cleaved by the 
REase [15–18, 53].
Interestingly, phage genome might be methylated by bacterial MTase upon 
successful injection into a host cell. Methylated recognition sites on viral genomes 
are therefore being protected from the cleavage and degradation by REase, leading 
to the initiation of the phage’s lytic cycle. Viral progeny remains insensitive to this 
specific bacterial REase until it infects a bacterium that possesses a different type 
of REase, in which case the new progeny will become unmethylated again and will, 
therefore, be sensitive to the R-M system of the cognate bacterium [28–31].
The fate of the host cell chiefly confides in the levels of R-M gene expression and 
ultimate proportion of the R-M enzymes and their competition for the sites in the 
invading phage genome [52].
Furthermore, some phages encode their own MTase that is cooperative with the 
host REase, and thereby viral DNA cannot be recognised as nonself. Phages can also 
stimulate the activity of host modification enzymes that can rapidly methylate viral 
DNA, thus protecting it from the activity of REase.
Alternatively, phages can bypass R-M systems by masking restriction sites. For 
example (Figure 7c), coliphage P1, while injecting its DNA into a host cell, it also 
co-injects host-genome-binding proteins (DarA and DarB) that mask R-M recogni-
tion sites [53, 54].
Figure 5. 
General representation of the bacterial restriction-modification (R-M) systems providing a defence against 
invading phage genomes. R-M systems consist of two contrasting enzymatic activities: a restriction endonuclease 
(REase) and a methyltransferase. REase recognises and cuts nonself unmethylated double-stranded DNA 
at specific recognition sites, whereas MTase adds methyl groups to the same genomic recognition sites on the 
bacterial DNA to protect self-genome from REase cleavage [50, 51]. Image courtesy of: https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC3591985/.
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As shown on an example of a Coliphage T7 (Figure 7d), some phages code 
for proteins that directly inhibit REase. Coliphage T7 possesses proteins that can 
mimic the DNA backbone. Ocr, a protein expressed by Coliphage T7, directly 
blocks the active site of some REases by mimicking 24 bp of bent B-form DNA, and 
it has a high affinity for the EcoKI REase component, thereby interfering with R-M 
system [53].
Lastly, phage-bacteria arm race allowed phages to gain capabilities of degrad-
ing necessary cofactors of R-M systems. For instance, coliphage T3 encodes 
S-adenosyl-l-methionine hydrolase that destroys an essential host R-M cofactor 
(the S-adenosyl-l-methionine). The removal of this necessary co-factor will 
lead to the inhibition of the REase, thereby successfully infecting the host cell 
[15–18].
5.2 CRISPR/Cas system
CRISPR along with CRISPR-associated (Cas) proteins is the type of adaptive 
heritable ‘immunity’ of bacteria, thus very specific and effective; and it is prevalent 
within the bacterial domain [55]. The CRISPR are DNA loci consisting of short 
palindromic repeats (identical in length and sequence), interspaced by segments 
of DNA sequences (spacer DNA) derived from previous exposures to phages. The 
spacer DNA sequences act as a ‘memory’, allowing bacteria to recognise and destroy 
specific phages in a subsequent infection. Genes encoding Cas proteins are adjacent 
to CRISPR loci [56].
Although some studies have suggested that CRISPRs can be used for pathogen 
subtyping [57], it has been found that CRISPR typing is not useful for the epide-
miological surveillance and outbreak investigation of Salmonella typhimurium [58].
Figure 6. 
Four distinct types of restriction-modification (R-M) systems. (a) Type I R-M system is composed of three 
subunits forming a complex: hsdR (restriction), hsdM (modification) and hsdS (specificity subunit that binds 
to an asymmetrical DNA sequence and determines the specificity of restriction and methylation). Two hsdM 
subunits and one hsdS subunit are involved in methylation of self-DNA. On the other hand, two complexes 
of hsdR, hsdM and hsdS (where each complex consists of two hsdR, two hsdM and one hsdS subunit) bind to 
the unmethylated recognition sites on phage DNA and cleave the DNA at random, far from their recognition 
sequences. Both reactions—methylation and cleavage—require ATP. (b) Type II R-M system is composed of 
two distinct enzymes: palindromic sequence methylating methyltransferase (mod) and endonuclease (res) 
that cleave unmethylated palindromic sequences close to or within the recognition sequence. (c) Type III R-M 
system is formed of methyltransferase (mod) and endonuclease (res) that form a complex. Methyltransferase 
transfers methyl group to one strand on the DNA, whereas two methyltransferases (endonuclease complexes) act 
together to bind to the complementary unmethylated recognition sites to cleave the DNA 24–26 bp away from 
the recognition site. (d) Type IV R-M system contains only endonuclease (res) that recognises methylated or 
modified DNA. Cleavage occurs within or away from the recognition sequences [26, 27, 50, 51]. Image courtesy 
of: https://www.annualreviews.org/doi/abs/10.1146/annurev-virology-031413-085500?journalCode=virology.
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The CRISPR/Cas phage resistance is mediated in three-step stages: adaptation 
(acquisition), where spacer phage-derived DNA sequences are incorporated into the 
CRISPR/Cas system; expression, where cas gene expression and CRISPR transcrip-
tion lead to pre-CRISPR RNA (pre-crRNA) that is then processed into CRISPR RNA 
(crRNA); and interference, during which the crRNA guides Cas proteins to the 
target (subsequently invading DNA) for the degradation. The cleavage of the target 
(proto-spacer) depends on the recognition of complementary sequences in spacer 
and protospacer [59, 60].
CRISPR/Cas systems have been classified into three major types: Types I, II 
and III, which are further divided into subtypes that require different types of Cas 
proteins. Although the CRISPR/Cas array is diverse among the bacteria and it is 
continuously co-evolving in response to the host-phage interactions, the defence 
activity in all three types of the CRISPR is comparable [21–23] Figure 8 illustrates 
the defence mechanisms in three distinct CRISPR/Cas arrays.
The Type II, CRISPR/Cas9, which was first identified in Streptococcus pyogenes, 
gained considerable interest within scientific studies as a precise genome editing tool. CRISPR/
Cas9 system is unique; a single Cas 9 protein (in addition to prevalent Cas 1 and Cas 2) is 
involved in the processing of crRNA and destruction of the target viral DNA [56, 61].
In the adaptation stage, phage-derived protospacer (snippet of DNA from the 
invading phage) is incorporated into the bacterial genome at the leader end of the 
CRISPR loci. In expression phase, the Cas9 gene expresses Cas9 protein possessing 
DNA cleaving HNH and RuvC-like nuclease domains; CRISPR locus is then tran-
scribed and processed into mature crRNA. Finally, in interference step, the complex 
Figure 7. 
Phage’s passive and active strategies to bypass restriction-modification (R-M) systems. (a) Phages that possess 
fewer restriction sites in their genome are less prone to DNA cleavage by the host restriction endonuclease 
(REase). (b) Occasionally phage DNA might be modified by bacterial methyltransferase (MTase) upon 
successful injection into a host cell. Methylated recognition sites on viral DNA are, therefore, being protected 
from the cleavage and degradation by REase, leading to the initiation of the phage’s lytic cycle. In addition, some 
phages encode their own MTase that is cooperative with the host REase; thus viral DNA cannot be recognised 
as nonself. (c) Some phages, for example, coliphage P1, while injecting its DNA into a host cell, it also co-injects 
host-genome-binding proteins (DarA and DarB) that mask R-M recognition sites. (d) Phages such as Coliphage 
T7 possess proteins that can mimic the DNA backbone. Ocr, a protein expressed by Coliphage T7, mimics the 
DNA phosphate backbone and has a high affinity for the EcoKI REase component, thereby interfering with 
R-M system. (e) In addition, some phages (e.g. Ral protein of Coliphage λ) can also stimulate activity of the 
bacterial modification enzyme in order to protect own DNA from the recognition by the bacterial REase as 
nonself. The peptide Stp encoded by Coliphage T4 can as well disrupt the structural conformation of the REase-
MTase complex [15–18]. Image courtesy of: https://www.nature.com/articles/nrmicro3096.
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consisting of Cas9, crRNA and separate trans-activating crRNA (tracrRNA) cleave 
20 base pairs crRNA-complementary target sequence that is adjacent to the proto-
spacer adjacent motif (PAM) [62].
To bypass CRISPR/Cas that has an incredibly dynamic rate of evolution, 
phages acquired array of strategies to succeed in propagation; this includes muta-
tions in the protospacers or in the PAM sequences and expression of anti-CRISPR 
proteins, and even some phages encode their own functional CRISPR/Cas systems 
[15–18, 63].
Figure 8. 
Image showing mechanisms of adaptation, expression and interference in three different types of CRISPR/Cas 
arrays. Type I and Type II CRISPR/Cas arrays rely on the protospacer adjacent motif (PAM), contained within 
phage nucleic acid, to ‘select’ the phage-derived protospacer. Next steps in the adaptation stage are similar in all 
three types; protospacer is incorporated by Cas 1 and Cas2 proteins into the bacterial genome at the leader end 
of the CRISPR loci to form a new spacer. In expression step, CRISPR loci are transcribed into pre-crRNA. The 
crRNA processing and interference stage is distinct in each type of the CRISPR/Cas system. In Type I, the 
multisubunit CRISPR-associated complex for antiviral defence (CASCADE) binds crRNA to locate the target, 
and with the presence of Cas3 protein, the invading target genome is degraded whereas in Type II, Cas9 protein 
is essential in the processing of the crRNA. TracrRNA recognises and attaches to the complementary sequences 
on the repeat region that is then cut by RNase III in the presence of Cas9. Lastly, in Type III, processing of pre-
crRNA into crRNA is dependent upon the activity of Cas6. Mature crRNA associated with Csm/Cmr complex 
targets foreign DNA or RNA for the degradation [21–23]. Image courtesy of: https://www.nature.com/articles/
nrmicro2577.
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Phages can evade interference step of Type I and Type II CRISPR/Cas system 
by a single point mutation or deletion in their protospacer region or in the PAM 
sequence (Figure 9). Phages with single-nucleotide substitutions or deletions 
positioned close to PAM sequence can bypass the CRISPR/Cas activity and complete 
their lytic cycles; in contrast, phages with multiple mutations at PAM-distal proto-
spacer positions do not [15–18, 28–31].
In some circumstances, however, although the phage successfully evades 
CRISPR/Cas interference, the host cell may survive by the acquisition of new 
spacer sequences (derived from invading phage) into their own CRISPR/Cas 
system. This new spacer provides the bacterium with an accelerated spectrum of 
phage resistance [15–18].
Prophages integrated within Pseudomonas aeruginosa possess genes that 
encode anti-CRISPR proteins directly suppressing CRISPR/Cas-mediated deg-
radation of the phage genome (Figure 10). According to Wiedenheft [64], these 
proteins might interrupt CRISPR RNA processing by preventing mature crRNA 
from binging to the crRNA-guide complex or by preventing the assembled 
crRNA-guided complex from interacting with target substrates through binding 
to it [64].
Prophages do not only contribute to bacterial resistance to invading phages, they 
can also encode proteins that contribute to bacterial virulence and antimicrobial 
resistance [58, 66].
Bacteria can also resist phages by possessing phage-inducible chromosomal 
islands (PICI) which prevent phage replication. Nevertheless, phages evolved 
their genomes to overcome this very specific antiviral strategy. For example, 
Vibrio cholerae ICP1 phages possess their own CRISPR/Cas systems that inacti-
vate PICI-like elements (PLE) in Vibrio cholerae (Figure 11). Studies conducted 
by Naser et al. [67] have shown that phage CRISPR arrays have evolved by the 
acquisition of new spacers targeting diverse regions of PLEs carried by Vibrio chol-
erae strains. Furthermore, the addition of the new spacers within phage CRISPR/
Cas loci enables the phages to expand their ability to counter PLE-mediated phage 
defence of diverse Vibrio cholerae strains [67].
Figure 9. 
Evasion by mutation. Mutations in the phage protospacers or in the PAM sequences allow the phage to escape 
interference step of the CRISPR/Cas system that would lead to the degradation of the phage genome [15–18]. 
Adapted image courtesy of: https://www.nature.com/articles/nrmicro3096.
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6. Overcoming host abortive infection systems: toxin-antitoxin
Abortive infection (Abi) systems promote cell death of the phage-infected 
bacteria, inhibiting phage replication and providing protection for bacterial 
populations [68].
Abi systems require both toxins and antagonistic antitoxins. Antitoxins are 
proteins or RNAs that protect bacterial cell from the activity of toxins in a typical 
cell life cycle, whereas toxins are the proteins encoded in toxin-antitoxin locus that 
Figure 10. 
Anti-CRISPR proteins expressed against CRISPR subtype I-F systems. Temperate phages such as Pseudomonas 
aeruginosa possess genes encoding anti-CRISPR proteins that directly interfere with the bacterial CRISPR/Cas 
system [15–18]. Adapted image courtesy of: https://www.nature.com/articles/nrmicro3096.
Figure 11. 
Phage-encoded CRISPR/Cas systems in Vibrio cholerae ICP1 phages. Upon adsorption and injection of viral 
genome into a host cell, phage crRNAs and CRISPR/Cas complexes are expressed and target phage-inducible 
chromosomal island (PICI) in the host genome; in the Vibrio cholerae, they are termed as PICI-like elements 
(PLE). If the spacers within phage CRISPR locus are complementary to the bacterial PLE, the CRISPR 
machinery is then able to specifically target this genetic element and inactivate it, leading to the viral 
propagation. However, in the absence of such targeting, phage CRISPR/Cas system can acquire new spacers to 
evolve rapidly and ensure effective targeting of the PLE to restore phage replication [15–18, 65]. Adapted image 
courtesy of: https://www.nature.com/articles/nrmicro3096.
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Figure 13. 
Escaping abortive infection mechanisms. (a) In a typical cell life cycle, antitoxins protect bacterial cell from the 
activity of toxins. (b) During phage infection, the expression of antitoxin encoding gene is suppressed, leading 
to the lethal activation of the toxin. (c) Mutations in certain phage genes can lead to escaping Abi systems 
activity, thereby a successful viral propagation without killing the host cell. (d) Some phages encode molecules 
that functionally replace the bacterial antitoxins, thus suppressing toxin activity and avoiding host cell death 
[15–18]. Image courtesy of: https://www.nature.com/articles/nrmicro3096.
Figure 12. 
Abortive infection (Abi) systems in Escherichia coli. The Rex system is a two-component Abi system. A phage 
protein-DNA complex (formed during phage replication) activates the sensor protein RexA, which in turn 
activates RexB. RexB is an ion channel that causes depolarisation of the bacterial membrane leading to cell 
death [28–31]. Image courtesy of Springer Nature: https://www.ncbi.nlm.nih.gov/pubmed/20348932.
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disrupt cellular metabolism (translation, replication and cell wall formation), caus-
ing cell death. During an infection, the expression of the antitoxin encoding gene 
is suppressed, leading to the lethal activation of the toxin [69]. Figure 12 illustrates 
the mechanism of Abi systems in Escherichia coli [70].
Interestingly, phages evolved an array of tactics to circumvent Abi systems. This 
includes mutations in specific phage genes and encoding own antitoxin molecules 
that suppresses bacterial toxin [15–18]. Figure 13 provides a broad overview of the 
strategies employed by the phages to by-pass Abi systems.
Bacteria-phage interaction is therefore very complex, and it is crucial to understand 
the molecular basis of this interaction and how bacteria and phages ‘fight’ each other. 
It has been reported that Anderson Phage Typing System of Salmonella Typhimurium 
can provide a valuable model system for study of phage-host interaction [71].
7. The potential application of phages as antibacterial therapeutics
The rapid emergence and dissemination of MDR bacteria seriously threaten 
global public health, as, without effective antibiotics, prevention and treatment of 
both community- and hospital-acquired infections may become unsuccessful and 
lead to widespread outbreaks.
Carbapenems and colistin are antibiotics of last resort, generally reserved to treat 
bacteria which are resistant to all other antibiotics. Until not long ago, colistin resis-
tance was only described as chromosomal, however, in 2016 Liu et al. reported the 
emergence of the first plasmid-mediated colistin resistance mechanism, MCR-1, in 
Enterobacteriaceae [72]. Furthermore, the increasing occurrence of colistin resistance 
among carbapenem-resistant Enterobacteriaceae has also been reported [73]. This 
is of significant concern as infections caused by colistin and carbapenem-resistant 
bacteria are very challenging to treat and control, as the treatment options are greatly 
limited or non-existent. Thus, the discovery and development of alternative antimi-
crobial therapeutics are the highest priorities of modern medicine and biotechnology.
Phages should be considered as great potential tools in MDR pathogens as they 
are species-specific (specificity prevents damage of normal microbiota), thus harm-
less to human; they have fast replication rate at the site of infection, and their short 
genomes can allow to further understand various molecular mechanisms implied 
to ‘fight’ bacteria. In addition, this understanding can enable scientists to ‘manipu-
late’ viral genomes and engineer a synthetic phage that combines the antibacterial 
characteristics of multiple phages into a single genome.
The escalating need for new antimicrobial agents attracted new attention in 
modern medicine, proposing several potential applications of phages as antibacte-
rial therapeutics including phage therapy, phage lysins and genetically-engineered 
phages.
7.1 Phage therapy
Phage therapy utilises strictly lytic phages that have bactericidal effect. As 
phages are host-specific, ‘phage cocktails’ containing multiple phages can broaden 
range of target cells. Nevertheless, selection of suitable phages is at the paramount 
to the successful elimination of clinically important pathogens, and it includes 
avoidance of adverse effects, such as anaphylaxis (adverse immune reaction) [74].
7.2 Phage-derived enzymes: lysins
In order to hydrolyse and degrade the bacterial cell wall, phages possess lysins.
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The spectrum of efficiency of natural lysins (derived from naturally occurring 
phages) is generally limited to Gram-positive bacteria; however, recombinant lysins 
have shown an ability to destabilise the outer membrane of Gram-negative bacteria 
and ultimately lead to rapid death of the target bacteria [74].
7.3 Bioengineered phages
Bioengineered phages have the potential to solve inherent limitations of natural 
phages such as narrow host range and evolution of resistance. Various genetic 
engineering methods have been proposed to design phages with extended anti-
microbial properties such as homologous recombination, phage recombineering 
of electroporated DNA, yeast-based platform, Gibson assembly and CRISPR/Cas 
genome editing [75].
Engineering of synthetic phages could be tailored to enhance the antibiotic 
activity, to reverse antibiotic resistance or to create sequence-specific  
antimicrobials [74].
8. Conclusions
The antagonistic host-phage relationship has led to the evolution of exception-
ally disperse phage-resistance mechanisms in the bacterial domain, including 
inhibition of phage adsorption, prevention of nucleic acid entry, Superinfection 
exclusion, cutting phage nucleic acids via restriction-modification systems and 
CRISPR, as well as abortive infection.
Evolvement of these mechanisms has been induced by constant parallel 
co-evolution of phages as they attempt to coexist. To survive, phages acquired 
diverse counterstrategies to circumvent bacterial anti-phage mechanisms such 
as adaptations to new receptors, digging for receptors and masking and modi-
fication of restriction sites and point mutations in specific genes and genome 
rearrangements that allow phages to evade bacterial antiviral systems such as 
CRISPR/Cas arrays, as well as mutations in specific genes to bypass abortive 
infection system. Conclusively, the co-evolving genetic variations and counter-
adaptations, in both bacteria and phages, drive the evolutionary bacteria-host 
arm race.
Besides, accumulating evidence shows that phages contribute to the antimi-
crobial resistance through horizontal gene transfer mechanisms. Indeed, many 
bacterial strains have become insensitive to the conventional antibiotics, posing 
a growing threat to human; and although in the past, western counties withdrew 
phage therapy in response to the discovery of therapeutic antibiotics, now, phage 
therapy regains an interest within the research community. There are apparent 
advantages of phage therapy, such as specificity, meaning only target bacteria 
would encounter lysis, but not healthy microbiota inhabiting human’s system. 
Additionally, ‘phage cocktails’, containing multiple bacteria-specific phages, could 
overcome the issue of phage-resistance as phages do adapt to these resistance 
mechanisms. However, ‘phage cocktails’ would require large numbers of phages 
that would have to be grown inside pathogenic bacteria in the laboratory, putting 
laboratory staff and the environment at risk.
Alternatively, building up the understanding of host-phage interactions and 
‘the war between bacteria and phages’ could potentially lead to defeating antimi-
crobial resistance by designing synthetic phages that can overcome the limitations 
of phage therapy.
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